Biological Effects of Transforming Growth Factor Beta in Human Cholangiocytes
by
, , , , , and
Elisa Ceccherini
1,*
,
Nicoletta Di Giorgi
1,
Elena Michelucci
1,
Giovanni Signore
2
,
Lorena Tedeschi
1,
Federico Vozzi
1,
Silvia Rocchiccioli
1 and
Antonella Cecchettini
1,3 1
Clinical Physiology Institute-CNR, 56124 Pisa, Italy
2
Biochemistry Unit, Department of Biology, University of Pisa, 56126 Pisa, Italy
3
Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy
*
Author to whom correspondence should be addressed.
Biology 2022, 11(4), 566; https://doi.org/10.3390/biology11040566
Submission received: 7 February 2022
/
Revised: 30 March 2022
/
Accepted: 5 April 2022
/
Published: 8 April 2022
(This article belongs to the Topic Molecular Profiling and Identification of Molecular Signatures Associated with Tissue Development, Tumorigenesis, and Anticancer Agents’ Action)
Simple Summary
Transforming growth factor β (TGF-β) is involved in fibrosis, and contributes to the progressive pathology of cholangiopathies. However, little is known regarding the effects and signaling of TGF-β in cholangiocytes. Here, we assessed the effects of TGF-β on proliferation, cell migration and cell cycle after 24 and 48 h. Proteomic approach was used to highlight proteins involved in these biological processes. In cholangiocytes, TGF-β reduced the proliferation rate and induced cell cycle arrest in G0/G1 phase. Proteomic analysis showed a downregulation of proteins involved in Ca2+ homeostasis, including CaM kinase II subunit delta, caveolin-1, NipSnap1 and calumin. Accordingly, Gene Ontology indicated that the plasma membrane and endoplasmic reticulum are the cellular compartments most perturbed following TGF-β treatment. In conclusion, our study highlighted the connection between TGF-β and Ca2+ homeostasis in cholangiocytes, and for the first time, correlated calumin and NipSnap1 to TGF-β signaling.
Abstract
TGF-β is a cytokine implicated in multiple cellular responses, including cell cycle regulation, fibrogenesis, angiogenesis and immune modulation. In response to pro-inflammatory and chemotactic cytokines and growth factors, cholangiocytes prime biliary damage, characteristic of cholangiopathies and pathologies that affect biliary tree. The effects and signaling related to TGF-β in cholangiocyte remains poorly investigated. In this study, the cellular response of human cholangiocytes to TGF-β was examined. Wound-healing assay, proliferation assay and cell cycle analyses were used to monitor the changes in cholangiocyte behavior following 24 and 48 h of TGF-β stimulation. Moreover, proteomic approach was used to identify proteins modulated by TGF-β treatment. Our study highlighted a reduction in cholangiocyte proliferation and a cell cycle arrest in G0/G1 phase following TGF-β treatment. Moreover, proteomic analysis allowed the identification of four downregulated proteins (CaM kinase II subunit delta, caveolin-1, NipSnap1 and calumin) involved in Ca2+ homeostasis. Accordingly, Gene Ontology analysis highlighted that the plasma membrane and endoplasmic reticulum are the cellular compartments most affected by TGF-β. These results suggested that the effects of TGF-β in human cholangiocytes could be related to an imbalance of intracellular calcium homeostasis. In addition, for the first time, we correlated calumin and NipSnap1 to TGF-β signaling.
Keywords:
cholangiocytes; TGF-β; proteomics
